Fool.com
The World's Greatest Investing Community
Results 71 - 80 of 513 : Previous 4 5 6 7 8 9 10 11 12 Next
The drugmaker cuts its losses after a disappointing trial on an osteoporosis drug.
Amgen's Climbing Up the Ladder
Positive trial data should help sales.
The Schizophrenic Drug Approval
Schering's drug gets a thumbs-up.
The Next Big Thing Is Not Right in Front of You
But one Fool things he knows where it is.
This Is Why Buffett's Buying Stocks
They're cheap. Enough said.
The Dumbest Investment I've Ever Seen
Here's what you should do instead.
No More Flower Power for Monsanto
Bye-bye, sunflower business.
It was fun while it lasted, ViroPharma.
These stocks have a shine and luster all their own.
A Tax Increase for Dividends and Capital Gains?
It might not be as bad as some fear.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK